These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6666217)
1. Importance of venodilation during long-term vasodilator therapy of chronic left ventricular failure. Franciosa JA; Leddy CL; Schwartz DE Z Kardiol; 1983; 72 Suppl 3():168-72. PubMed ID: 6666217 [TBL] [Abstract][Full Text] [Related]
2. Advantage of combined therapy with captopril and nitrates in severe congestive heart failure. Halon DA; Rosenfeld T; Hardoff R; Lewis BS Isr J Med Sci; 1988 Nov; 24(11):664-70. PubMed ID: 3063685 [TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of vasodilators and long-term response in heart failure. Franciosa JA; Dunkman WB; Leddy CL J Am Coll Cardiol; 1984 Jun; 3(6):1521-30. PubMed ID: 6325522 [TBL] [Abstract][Full Text] [Related]
4. Acute and chronic isosorbide dinitrate therapy in congestive heart failure: demonstration of improved exercise capacity and differing arterial and venous tolerance during chronic administration. Leier CV; Huss P; Magorien RD; Unverferth DV Z Kardiol; 1983; 72 Suppl 3():173-7. PubMed ID: 6666218 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure. Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275 [TBL] [Abstract][Full Text] [Related]
6. [Acute hemodynamic effects of pimobendan and captopril: a comparative study in the same patients with chronic heart failure]. Tsuda T; Izumi T; Kodama M; Hanawa H; Ohshima M; Takahashi M; Suzuki M; Aizaki T; Uchiyama H; Shibata A J Cardiol; 1992; 22(4):721-9. PubMed ID: 1343639 [TBL] [Abstract][Full Text] [Related]
7. [Captopril therapy in chronic congestive heart failure]. Morgera T; Humar F; Mestroni L; Maras P; Camerini F G Ital Cardiol; 1983; 13(1):39-46. PubMed ID: 6347789 [TBL] [Abstract][Full Text] [Related]
8. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure. Mahgoub AA; El-Medany AH; Abdulatif AS Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557 [TBL] [Abstract][Full Text] [Related]
9. [Hemodynamic effects of molsidomine in chronic congestive heart failure]. Humar F; Maras P; Musitelli G; Camerini F G Ital Cardiol; 1986 May; 16(5):427-32. PubMed ID: 3755413 [TBL] [Abstract][Full Text] [Related]
10. [Treatment of congestive cardiac failure with vasodilators (author's transl)]. Hauf GF; Bubenheimer P; Lönne E; Roskamm H Dtsch Med Wochenschr; 1981 Nov; 106(48):1607-12. PubMed ID: 7307999 [TBL] [Abstract][Full Text] [Related]
11. Transpulmonary B-type natriuretic peptide uptake and cyclic guanosine monophosphate release in heart failure and pulmonary hypertension: the effects of sildenafil. Melenovsky V; Al-Hiti H; Kazdova L; Jabor A; Syrovatka P; Malek I; Kettner J; Kautzner J J Am Coll Cardiol; 2009 Aug; 54(7):595-600. PubMed ID: 19660688 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic evaluation during exercise test after acute and chronic ibopamine treatment in patients with congestive heart failure. Gavazzi A; Mussini A; Bramucci E Arzneimittelforschung; 1986 Feb; 36(2A):366-70. PubMed ID: 3707652 [TBL] [Abstract][Full Text] [Related]
13. Early and medium term results of tailored therapy for heart failure. Martins S; Soares RM; do Rosário L; Quininha J; Antunes AM Rev Port Cardiol; 2001 Mar; 20(3):261-82. PubMed ID: 11417309 [TBL] [Abstract][Full Text] [Related]
14. Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure. Ren JH; Unverferth DV; Magorien RD; Leier CV Arch Intern Med; 1985 Apr; 145(4):641-4. PubMed ID: 3985726 [TBL] [Abstract][Full Text] [Related]
15. Long-term effect of isosorbide dinitrate and nifedipine, singly and in association, in patients with chronic heart failure. Jezek V; Jezková J; Michaljanic A; Niederle P; Feuereisl R Eur Heart J; 1990 Dec; 11(12):1059-64. PubMed ID: 2292252 [TBL] [Abstract][Full Text] [Related]
16. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure. Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283 [TBL] [Abstract][Full Text] [Related]
17. [Acute hemodynamic and coronary effects of captopril in chronic cardiac failure]. Ourbak P; Pornin M; Melanidis J; Bouziri S; Allal J; Sellier P; Maurice P Arch Mal Coeur Vaiss; 1984 Aug; 77(8):865-71. PubMed ID: 6435565 [TBL] [Abstract][Full Text] [Related]
18. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors. Chow MS Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997 [TBL] [Abstract][Full Text] [Related]
19. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease. Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603 [TBL] [Abstract][Full Text] [Related]
20. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure. Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]